(TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV (R) (enfortumab vedotin-ejfv), a Nectin-4 directed ...
Discover why UroGen Pharma (URGN) is rated a strong buy for 2026, with innovative cancer therapies and high growth potential.
Thanks to messy weather, extended darkness and an annual surge of travelers, driving can be dangerous around the holidays – ...
The U.S. Agricultural Export Development Council elected Karen Horan from the National Confectioners Association as chair.